NPCE

Neuropace Inc

13.66

+0.13+0.96%

After Hours: 13.66 0.00 0.00%16:10 03/26 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE13.36/13.53

TODAY RANGE13.36-13.74

VOL170.54K

MARKET CAP459.89M

52 WEEK RANGE7.56-18.98

AVG VOL (3M)218.48K

% TURNOVER0.51%

TURNOVER--

P/E (TTM)-20.8232

% RANGE2.73%

EPS(TTM)-0.6560

P/E(FORWARD)-19.2394

P/B24.10

BVPS0.5668

DIVIDEND--

P/S4.587

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP354.61M

SHARES OUTSTANDING33.67M

NEXT EARNINGS05/11-05/15

FREE FLOAT25.96M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·03/18 14:30
Analysts Are Bullish on These Healthcare Stocks: Kestra Medical Technologies Ltd. (KMTS), NeuroPace (NPCE)
TipRanks·03/18 10:25
NeuroPace assumed with an Overweight at Wells Fargo
TipRanks·03/06 12:03
NeuroPace (NPCE) Receives a Buy from Wells Fargo
Reuters·03/05 21:30
NeuroPace to Present at Leerink 2026 Global Healthcare Conference
TipRanks·03/05 06:00
Regulatory Shutdowns Threaten Neuropace’s FDA Approvals and Capital Market Access
Reuters·03/04 21:44
Neuropace Chief Medical Officer Martha Morrell Disposes of Common Shares
Seeking Alpha·03/04 02:02
NeuroPace reiterates $98M–$100M 2026 revenue target while advancing AI and IGE pipeline
Reuters·03/03 22:03
NeuroPace forecasts 2026 revenue of $98 million to $100 million
Reuters·03/03 21:27
NeuroPace Q4 revenue rises
Dow Jones·03/03 21:19
*NeuroPace Sees 1Q Rev $21M-$22M >NPCE
Dow Jones·03/03 21:16
*NeuroPace Continues to Expect IGE Contribution Following Potential NAUTILUS PMA-Supplement Approval in Mid-2026 >NPCE
Dow Jones·03/03 21:05
Press Release: NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
TipRanks·03/03 13:56
NeuroPace (NPCE) Receives a Buy from Lake Street
Dow Jones·02/20 21:39
Press Release: NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026
Reuters·02/20 21:30
NeuroPace Inc. Schedules Fourth-Quarter Financial Results Webcast and Conference Call

Same Industry

Name/Symbol

Change%

Price

NPCE

Thermo Fishr Sci

TMO

+2.10%

488.17

Waters

WAT

+0.94%

301.81

Danaher Corporation

DHR

+0.34%

190.00

Fulgent Genetics

FLGT

+0.06%

16.34

RMD

Check Point Software Tech Ltd

CHKP

-1.16%

152.73

Agilent Technologies Inc

-0.40%

111.30

Abiomed Inc

ABMD

0.00%

381.02

GEHC

ISRG

Veeva Sys Inc

VEEV

-3.30%

179.11

Revvity Inc

RVTY

+0.21%

85.94

Edwards Lifesciences Corp

-0.40%

81.69

Inmode Ltd.

INMD

-0.22%

13.70

ATHN

BRKR

VARIAN MEDICAL

VAR

0.00%

0.0000

ITGR

Hologic Inc

HOLX

+0.11%

75.41

Quidel

QDEL

-2.30%

16.17

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.